Literature DB >> 20559580

Differential impact of lactose/lactase phenotype on colonic microflora.

Andrew Szilagyi1, Ian Shrier, Debra Heilpern, Jung Je, Sunghoon Park, George Chong, Catherine Lalonde, Louis-Francois Cote, Byong Lee.   

Abstract

BACKGROUND: The ability to digest lactose divides the world's population into two phenotypes that may be risk variability markers for several diseases. Prebiotic effects likely favour lactose maldigesters who experience lactose spilling into their colon.
OBJECTIVE: To evaluate the effects of fixed-dose lactose solutions on fecal bifidobacteria and lactobacilli in digesters and maldigesters, and to determine whether the concept of a difference in ability to digest lactose is supported.
METHODS: A four-week study was performed in 23 lactose maldigesters and 18 digesters. Following two weeks of dairy food withdrawal, subjects ingested 25 g of lactose twice a day for two weeks. Stool bifidobacteria and lactobacilli counts pre- and postintervention were measured as the primary outcome. For secondary outcomes, total anaerobes, Enterobacteriaceae, beta-galactosidase and N-acetyl-beta-D-glucosaminidase activity in stool, as well as breath hydrogen and symptoms following lactose challenge tests, were measured.
RESULTS: Lactose maldigesters had a mean change difference (0.72 log10 colony forming unitsg stool; P=0.04) in bifidobacteria counts compared with lactose digesters. Lactobacilli counts were increased, but not significantly. Nevertheless, reduced breath hydrogen after lactose ingestion correlated with lactobacilli (r=-0.5; P<0.001). Reduced total breath hydrogen and symptom scorestogether, with a rise in fecal enzymes after intervention, were appropriate, but not significant.
CONCLUSIONS: Despite failure to achieve full colonic adaptation, the present study provided evidence for a differential impact of lactose on microflora depending on genetic lactase status. A prebiotic effect was evident in lactose maldigesters but not in lactose digesters. This may play a role in modifying the mechanisms of certain disease risks related to dairy food consumption between the two phenotypes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20559580      PMCID: PMC2898492          DOI: 10.1155/2010/649312

Source DB:  PubMed          Journal:  Can J Gastroenterol        ISSN: 0835-7900            Impact factor:   3.522


  48 in total

1.  Mosaic pattern of lactase expression by villous enterocytes in human adult-type hypolactasia.

Authors:  L Maiuri; V Raia; J Potter; D Swallow; M W Ho; R Fiocca; G Finzi; M Cornaggia; C Capella; A Quaroni
Journal:  Gastroenterology       Date:  1991-02       Impact factor: 22.682

2.  Comparison of a real-time polymerase chain reaction assay for lactase genetic polymorphism with standard indirect tests for lactose maldigestion.

Authors:  Andrew Szilagyi; Paula Malolepszy; Elise Hamard; Xiaoqing Xue; Nir Hilzenrat; Mary Ponniah; Elizabeth MacNamara; George Chong
Journal:  Clin Gastroenterol Hepatol       Date:  2006-07-28       Impact factor: 11.382

Review 3.  The effect of lactose maldigestion on the relationship between dairy food intake and colorectal cancer: a systematic review.

Authors:  Andrew Szilagyi; Usha Nathwani; Christina Vinokuroff; José A Correa; Ian Shrier
Journal:  Nutr Cancer       Date:  2006       Impact factor: 2.900

4.  In vitro and in vivo lactose and lactulose effects on colonic fermentation and portal-systemic encephalopathy parameters.

Authors:  M Uribe-Esquivel; S Moran; J L Poo; R M Muñoz
Journal:  Scand J Gastroenterol Suppl       Date:  1997

Review 5.  Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics.

Authors:  G R Gibson; M B Roberfroid
Journal:  J Nutr       Date:  1995-06       Impact factor: 4.798

6.  In vitro lactose fermentation by human colonic bacteria is modified by Lactobacillus acidophilus supplementation.

Authors:  T Jiang; D A Savaiano
Journal:  J Nutr       Date:  1997-08       Impact factor: 4.798

Review 7.  Using breath tests wisely in a gastroenterology practice: an evidence-based review of indications and pitfalls in interpretation.

Authors:  Joseph Romagnuolo; Dan Schiller; Robert J Bailey
Journal:  Am J Gastroenterol       Date:  2002-05       Impact factor: 10.864

8.  Treatment of chronic portal-systemic encephalopathy with lactose in lactase-deficient patients.

Authors:  M Uribe; M A Márquez; G García-Ramos; V Escobedo; H Murillo; L Guevara; R Lisker
Journal:  Dig Dis Sci       Date:  1980-12       Impact factor: 3.199

9.  Lactulose ingestion increases faecal bifidobacterial counts: a randomised double-blind study in healthy humans.

Authors:  Y Bouhnik; A Attar; F A Joly; M Riottot; F Dyard; B Flourié
Journal:  Eur J Clin Nutr       Date:  2004-03       Impact factor: 4.016

10.  The capacity of short-chain fructo-oligosaccharides to stimulate faecal bifidobacteria: a dose-response relationship study in healthy humans.

Authors:  Yoram Bouhnik; Laurent Raskine; Guy Simoneau; Damien Paineau; Francis Bornet
Journal:  Nutr J       Date:  2006-03-28       Impact factor: 3.271

View more
  16 in total

Review 1.  Adult lactose digestion status and effects on disease.

Authors:  Andrew Szilagyi
Journal:  Can J Gastroenterol Hepatol       Date:  2015-04

2.  Association of the LCT-13910C>T polymorphism with obesity and its modulation by dairy products in a Mediterranean population.

Authors:  Dolores Corella; Maria Arregui; Oscar Coltell; Olga Portolés; Patricia Guillem-Sáiz; Paula Carrasco; Jose V Sorlí; Carolina Ortega-Azorín; Jose I González; Jose M Ordovás
Journal:  Obesity (Silver Spring)       Date:  2010-12-30       Impact factor: 5.002

3.  UEG Week 2020 Oral Presentations.

Authors: 
Journal:  United European Gastroenterol J       Date:  2020-10       Impact factor: 4.623

4.  Short-Term Dairy Product Elimination and Reintroduction Minimally Perturbs the Gut Microbiota in Self-Reported Lactose-Intolerant Adults.

Authors:  Elizabeth K Costello; Oren Kolodny; David A Relman; Courtney J Smith; Les Dethlefsen; Christopher Gardner; Linda Nguyen; Marcus Feldman
Journal:  mBio       Date:  2022-06-13       Impact factor: 7.786

Review 5.  Development of Personalized Nutrition: Applications in Lactose Intolerance Diagnosis and Management.

Authors:  Millie Porzi; Kathryn J Burton-Pimentel; Barbara Walther; Guy Vergères
Journal:  Nutrients       Date:  2021-04-29       Impact factor: 5.717

6.  Improving lactose digestion and symptoms of lactose intolerance with a novel galacto-oligosaccharide (RP-G28): a randomized, double-blind clinical trial.

Authors:  Dennis A Savaiano; Andrew J Ritter; Todd R Klaenhammer; Gareth M James; Amy T Longcore; Justin R Chandler; W Allan Walker; Howard L Foyt
Journal:  Nutr J       Date:  2013-12-13       Impact factor: 3.271

Review 7.  Lactose intolerance and gastrointestinal cow's milk allergy in infants and children - common misconceptions revisited.

Authors:  Ralf G Heine; Fawaz AlRefaee; Prashant Bachina; Julie C De Leon; Lanlan Geng; Sitang Gong; José Armando Madrazo; Jarungchit Ngamphaiboon; Christina Ong; Jossie M Rogacion
Journal:  World Allergy Organ J       Date:  2017-12-12       Impact factor: 4.084

8.  Gut-microbiome-related LCT genotype and 2-year changes in body composition and fat distribution: the POUNDS Lost Trial.

Authors:  Yoriko Heianza; Dianjianyi Sun; Wenjie Ma; Yan Zheng; Catherine M Champagne; George A Bray; Frank M Sacks; Lu Qi
Journal:  Int J Obes (Lond)       Date:  2018-02-26       Impact factor: 5.095

Review 9.  Adaptation to Lactose in Lactase Non Persistent People: Effects on Intolerance and the Relationship between Dairy Food Consumption and Evalution of Diseases.

Authors:  Andrew Szilagyi
Journal:  Nutrients       Date:  2015-08-13       Impact factor: 5.717

10.  Effects of Whole Milk Supplementation on Gut Microbiota and Cardiometabolic Biomarkers in Subjects with and without Lactose Malabsorption.

Authors:  Xiaoqin Li; Jiawei Yin; Yalun Zhu; Xiaoqian Wang; Xiaoli Hu; Wei Bao; Yue Huang; Liangkai Chen; Sijing Chen; Wei Yang; Zhilei Shan; Liegang Liu
Journal:  Nutrients       Date:  2018-10-02       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.